Business Context and Reporting Period
This Form 8-K Current Report was filed by MRI Interventions, Inc. (not Clearpoint Neuro, Inc.) on March 25, 2014, with the earliest event reported on that date. The filing details the completion of a private placement financing transaction involving the sale of debt securities and warrants to accredited investors.
Key Financial Metrics
- Gross Proceeds: $3,725,000 received from the sale of notes.
- Debt Issued: 12% second-priority secured non-convertible promissory notes with a total aggregate principal amount of $3,725,000.
- Debt Maturity: March 25, 2019.
- Interest Rate: 12% per annum, payable semi-annually in arrears.
- Warrants Issued: Warrants to purchase up to 1,117,500 shares of common stock issued to investors, plus 72,750 warrants issued to placement agents.
- Warrant Exercise Price: $1.75 per share.
- Transaction Costs: Placement agents received cash commissions of $145,500 plus warrants.
Material Changes
The primary material change is the creation of a direct financial obligation through the issuance of the Notes and the dilution potential from the issuance of Warrants. The filing does not provide comparative financial data (revenue, profit, or cash flow) for prior periods as this is a transaction-specific report rather than a periodic financial statement.
Outlook, Risks, and Terms
- Prepayment Terms: Prepayment without penalty is permitted after March 25, 2017. Prior to that date, prepayment of all principal and accrued interest is allowed subject to a prepayment premium.
- Security Interest: The Notes are secured by a second-priority security interest in the Company's property and assets.
- Events of Default: Include failure to pay interest, breach of covenants, failure to pay other indebtedness, and insolvency or bankruptcy events. Upon default, majority holders can declare the Notes due and payable.
- Warrant Features: Warrants are exercisable for five years and include a "cashless exercise" feature and adjustments for corporate events like stock splits.
Investor Verification Checklist
- Verify the Company's current liquidity position to ensure it can meet semi-annual interest payments of 12% on $3.725 million.
- Confirm the status of the "second-priority" security interest to understand the hierarchy of claims against company assets.
- Review the specific prepayment premium terms applicable before March 25, 2017, as these affect refinancing flexibility.
- Assess the potential dilution impact of 1,190,250 total warrants (investor and agent) exercisable at $1.75 per share.
- Check for any existing indebtedness that might trigger cross-default clauses mentioned in the Notes.